Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Italfarmaco
Italfarmaco
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Tiglutik
Riluzole
2018-09-05
2024-2029
Amyotrophic lateral sclerosis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Givinostat
drug interactions
,
hepatic insufficiency
,
juvenile arthritis
,
arthritis
,
lymphoma
,
hodgkin disease
,
polycythemia
,
myeloproliferative disorders
,
hereditary autoinflammatory diseases
,
syndrome
,
schnitzler syndrome
,
multiple myeloma
,
plasma cell neoplasms
,
neoplasms
,
leukemia
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
crohn disease
,
duchenne muscular dystrophy
,
muscular dystrophies
,
polycythemia vera
,
rare diseases
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use